Menu Close

Stay informed on the latest in arthritis prevention, research, treatment and care with JointHealth™ express, Canada's trusted source for arthritis news. Delivered right to your inbox, this "breaking news" bulletin provides timely updates on key arthritis topics, including disease management, research breakthroughs, and treatment advancements. As the longest-running arthritis news source in Canada, JointHealth™ express provides you expert insights from patients and analysis from arthritis health care professionals to help you on your arthritis journey. Stay connected to the arthritis information that matters most.

Click here to see JointHealth™ express bulletins from 2023 and earlier.

Latest News

Arthritis At Home 275 – Moving more with inflammatory arthritis and strategies for behaviour change

National Health and Fitness Day – an annual coast-to-coast celebration of wellness – is held on the first Saturday ...
Read More

Arthritis At Home 274 – Inflammatory bowel disease and its connection with spondyloarthritis

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Kerri Novak, an Assistant ...
Read More

JointHealth™ insight – May 2025

Canada's urgent health priority Arthritis impacts more people in Canada than diabetes, heart disease, cancer, stroke, and dementia combined ...
Read More

New blog post from Joint Journeys, life with arthritis by Carrie: RA on the trail

In her latest blog post, Carrie shares tips on medications management and foot care while on the trail. Although ...
Read More

Arthritis At Home 273 – Safety of rituximab, antinuclear antibody testing in lupus, and deprescribing

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Arielle Mendel, an Assistant ...
Read More

Update on availability of infliximab biosimilar Inflectra®

The infliximab biosimilar Inflectra® will be discontinued in Canada as of September 30, 2025. This means that patients currently receiving ...
Read More

Arthritis At Home 272 – Making artificial intelligence in medicine a reality

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Muhammad Mamdani, Vice President ...
Read More

Call for patient input on upadacitinib (Rinvoq®) for giant cell arteritis

Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s ...
Read More

Arthritis At Home 271 – Lupus and pregnancy in women in Alberta

Saturday, May 10 is World Lupus Day – an annual day dedicated to people living with lupus. Lupus is ...
Read More

Call for patient input on inebilizumab (Uplizna®) for immunoglobulin G4-related disease

Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s ...
Read More

Arthritis At Home 270 – First-line targeted therapy for axial spondyloarthritis

Saturday, May 3 is World AS Day – an annual day dedicated to people living with axial spondyloarthritis (axSpA) ...
Read More

Are you participating in any exercise programs as part of your recovery after your hip or knee replacement surgery?

Dear ACE Members, Have you had a hip or knee replacement? After your physiotherapy sessions were done, did you participate ...
Read More